Literature DB >> 7544234

Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects.

D P Skoner1, W J Doyle, E P Tanner, J Kiss, P Fireman.   

Abstract

The economic impact and medical complication rate of the common cold are well documented, but many of the physiological, inflammatory, and immune responses to common cold viruses have only recently been investigated. The purpose of this study was to compare selected systemic immune and inflammatory responses to experimental rhinovirus (RV)-39 challenge in seronegative allergic rhinitis and non-allergic rhinitis subjects. Peripheral blood was obtained before (baseline), during (acute), and 23 days after (convalescent) RV-39 intranasal challenge and assayed for leucocyte histamine release, serum immunoglobulins, allergen-specific IgE antibodies, plasma histamine, and platelet aggregation. All subjects were infected, as manifested by viral shedding in nasal secretions or seroconversion. RV-39 infection induced significant acute increases in serum IgE, leucocyte histamine release, and platelet aggregation, but caused no changes in serum IgG, serum IgA, serum IgM, and plasma histamine. The first change was confined to the allergic rhinitis subjects. There was no evidence that the acute rise in total serum IgE was due to an elevation of a pre-existing, pollen-specific serum IgE antibody. The results show that intranasal challenge with RV-39 induced changes in systemic immune and inflammatory parameters with a unique response pattern in allergic rhinitis subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544234     DOI: 10.1111/j.1365-2222.1995.tb01095.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  12 in total

Review 1.  Mechanisms of virus induced exacerbations of asthma.

Authors:  J M Corne; S T Holgate
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection.

Authors:  D Gentile; W Doyle; T Whiteside; P Fireman; F G Hayden; D Skoner
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

3.  Evaluation of serum immunoglobulin E levels in bronchial asthma.

Authors:  Thirunavukkarasu Sandeep; Mysore Subrahmanyam Roopakala; Chickballapur Rayappa Wilma Delphine Silvia; Srikantaiah Chandrashekara; Mohan Rao
Journal:  Lung India       Date:  2010-07

Review 4.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 5.  Immune pathways for translating viral infection into chronic airway disease.

Authors:  Michael J Holtzman; Derek E Byers; Loralyn A Benoit; John T Battaile; Yingjian You; Eugene Agapov; Chaeho Park; Mitchell H Grayson; Edy Y Kim; Anand C Patel
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 6.  Host immune responses to rhinovirus: mechanisms in asthma.

Authors:  John T Kelly; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2008-10       Impact factor: 10.793

Review 7.  The Role of Environmental Risk Factors on the Development of Childhood Allergic Rhinitis.

Authors:  Allison C Wu; Amber Dahlin; Alberta L Wang
Journal:  Children (Basel)       Date:  2021-08-17

Review 8.  New immune pathways from chronic post-viral lung disease.

Authors:  Loralyn A Benoit; Michael J Holtzman
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 9.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

10.  Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia.

Authors:  Mitchell H Grayson; Dorothy Cheung; Michelle M Rohlfing; Robert Kitchens; Daniel E Spiegel; Jennifer Tucker; John T Battaile; Yael Alevy; Le Yan; Eugene Agapov; Edy Y Kim; Michael J Holtzman
Journal:  J Exp Med       Date:  2007-10-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.